These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 37319434)

  • 1. The non-cell-autonomous function of ID1 promotes AML progression via ANGPTL7 from the microenvironment.
    Fei MY; Wang Y; Chang BH; Xue K; Dong F; Huang D; Li XY; Li ZJ; Hu CL; Liu P; Wu JC; Yu PC; Hong MH; Chen SB; Xu CH; Chen BY; Jiang YL; Liu N; Zhao C; Jin JC; Hou D; Chen XC; Ren YY; Deng CH; Zhang JY; Zong LJ; Wang RJ; Gao FF; Liu H; Zhang QL; Wu LY; Yan J; Shen S; Chang CK; Sun XJ; Wang L
    Blood; 2023 Sep; 142(10):903-917. PubMed ID: 37319434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of bone marrow microenvironment (BMM) cells in acute myeloid leukemia (AML) progression: immune checkpoints, metabolic checkpoints, and signaling pathways.
    Bakhtiyari M; Liaghat M; Aziziyan F; Shapourian H; Yahyazadeh S; Alipour M; Shahveh S; Maleki-Sheikhabadi F; Halimi H; Forghaniesfidvajani R; Zalpoor H; Nabi-Afjadi M; Pornour M
    Cell Commun Signal; 2023 Sep; 21(1):252. PubMed ID: 37735675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiR-29b/Sp1/FUT4 axis modulates the malignancy of leukemia stem cells by regulating fucosylation via Wnt/β-catenin pathway in acute myeloid leukemia.
    Liu B; Ma H; Liu Q; Xiao Y; Pan S; Zhou H; Jia L
    J Exp Clin Cancer Res; 2019 May; 38(1):200. PubMed ID: 31097000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential inflammatory conditioning of the bone marrow by acute myeloid leukemia and its impact on progression.
    Minciacchi VR; Karantanou C; Bravo J; Pereira RS; Zanetti C; Krack T; Kumar R; Bankov K; Hartmann S; Huntly BJP; Meduri E; Ruf W; Krause DS
    Blood Adv; 2024 Oct; 8(19):4983-4996. PubMed ID: 38996202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Role of Hypoxic Bone Marrow Microenvironment in Acute Myeloid Leukemia and Future Therapeutic Opportunities.
    Bruno S; Mancini M; De Santis S; Monaldi C; Cavo M; Soverini S
    Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34202238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute myeloid leukemia transforms the bone marrow niche into a leukemia-permissive microenvironment through exosome secretion.
    Kumar B; Garcia M; Weng L; Jung X; Murakami JL; Hu X; McDonald T; Lin A; Kumar AR; DiGiusto DL; Stein AS; Pullarkat VA; Hui SK; Carlesso N; Kuo YH; Bhatia R; Marcucci G; Chen CC
    Leukemia; 2018 Mar; 32(3):575-587. PubMed ID: 28816238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of AKT signaling by Id1 controls t(8;21) leukemia initiation and progression.
    Wang L; Man N; Sun XJ; Tan Y; García-Cao M; Liu F; Hatlen M; Xu H; Huang G; Mattlin M; Mehta A; Rampersaud E; Benezra R; Nimer SD
    Blood; 2015 Jul; 126(5):640-50. PubMed ID: 26084673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leukemia stem cell-bone marrow microenvironment interplay in acute myeloid leukemia development.
    Yao Y; Li F; Huang J; Jin J; Wang H
    Exp Hematol Oncol; 2021 Jul; 10(1):39. PubMed ID: 34246314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA damage to bone marrow stromal cells by antileukemia drugs induces chemoresistance in acute myeloid leukemia via paracrine FGF10-FGFR2 signaling.
    Yu S; Ye J; Wang Y; Lu T; Liu Y; Liu N; Zhang J; Lu F; Ma D; Gale RP; Ji C
    J Biol Chem; 2023 Jan; 299(1):102787. PubMed ID: 36509141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential role of Id1 in MLL-AF9-driven leukemia based on cell of origin.
    Man N; Sun XJ; Tan Y; García-Cao M; Liu F; Cheng G; Hatlen M; Xu H; Shah R; Chastain N; Liu N; Huang G; Zhou Y; Sheng M; Song J; Yang FC; Benezra R; Nimer SD; Wang L
    Blood; 2016 May; 127(19):2322-6. PubMed ID: 26944543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mesenchymal stromal cells derived from acute myeloid leukemia bone marrow exhibit aberrant cytogenetics and cytokine elaboration.
    Huang JC; Basu SK; Zhao X; Chien S; Fang M; Oehler VG; Appelbaum FR; Becker PS
    Blood Cancer J; 2015 Apr; 5(4):e302. PubMed ID: 25860293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance of up-regulated ID1 expression in Chinese de novo acute myeloid leukemia.
    Zhou JD; Yang L; Zhu XW; Wen XM; Yang J; Guo H; Chen Q; Yao DM; Ma JC; Lin J; Qian J
    Int J Clin Exp Pathol; 2015; 8(5):5336-44. PubMed ID: 26191235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A potential area of use for immune checkpoint inhibitors: Targeting bone marrow microenvironment in acute myeloid leukemia.
    Aru B; Pehlivanoğlu C; Dal Z; Dereli-Çalışkan NN; Gürlü E; Yanıkkaya-Demirel G
    Front Immunol; 2023; 14():1108200. PubMed ID: 36742324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting the bone marrow microenvironment in acute leukemia.
    Karantanou C; Godavarthy PS; Krause DS
    Leuk Lymphoma; 2018 Nov; 59(11):2535-2545. PubMed ID: 29431560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High Id1 expression is associated with poor prognosis in 237 patients with acute myeloid leukemia.
    Tang R; Hirsch P; Fava F; Lapusan S; Marzac C; Teyssandier I; Pardo J; Marie JP; Legrand O
    Blood; 2009 Oct; 114(14):2993-3000. PubMed ID: 19643984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repression of Mcl-1 expression by the CDC7/CDK9 inhibitor PHA-767491 overcomes bone marrow stroma-mediated drug resistance in AML.
    O' Reilly E; Dhami SPS; Baev DV; Ortutay C; Halpin-McCormick A; Morrell R; Santocanale C; Samali A; Quinn J; O'Dwyer ME; Szegezdi E
    Sci Rep; 2018 Oct; 8(1):15752. PubMed ID: 30361682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute myeloid leukemia induces protumoral p16INK4a-driven senescence in the bone marrow microenvironment.
    Abdul-Aziz AM; Sun Y; Hellmich C; Marlein CR; Mistry J; Forde E; Piddock RE; Shafat MS; Morfakis A; Mehta T; Di Palma F; Macaulay I; Ingham CJ; Haestier A; Collins A; Campisi J; Bowles KM; Rushworth SA
    Blood; 2019 Jan; 133(5):446-456. PubMed ID: 30401703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5-Demethylnobiletin Inhibits Cell Proliferation, Downregulates ID1 Expression, Modulates the NF-κB/TNF-α Pathway and Exerts Antileukemic Effects in AML Cells.
    Chen PY; Wang CY; Tsao EC; Chen YT; Wu MJ; Ho CT; Yen JH
    Int J Mol Sci; 2022 Jul; 23(13):. PubMed ID: 35806401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LC3-associated phagocytosis in bone marrow macrophages suppresses acute myeloid leukemia progression through STING activation.
    Moore JA; Mistry JJ; Hellmich C; Horton RH; Wojtowicz EE; Jibril A; Jefferson M; Wileman T; Beraza N; Bowles KM; Rushworth SA
    J Clin Invest; 2022 Mar; 132(5):. PubMed ID: 34990402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Expression and clinical significance of ID1 gene in acute myeloid leukemia].
    Lu Y; Wang Q; Mu QT; Chen ZM; Lou JY; Ni WM; Jin J
    Zhonghua Xue Ye Xue Za Zhi; 2012 Apr; 33(4):278-81. PubMed ID: 22781717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.